|
Press Releases |
|
|
|
Tuesday, May 30, 2023 |
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
Monday, December 19, 2022 |
|
Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets |
Gelonghui released a Press Release on "China Medical System Holdings Limited's innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets ('the Product') has obtained positive results for its Phase III clinical trial in China." more info >> |
|
Friday, November 18, 2022 |
|
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally |
Recently, the S&P Global Corporate Sustainability Assessment (S&P Global CSA) released the 2022 Environmental, Social and Governance (ESG) scores for China Medical System Holdings Limited ("CMS" or the "Group"). CMS achieved a significant improvement with a score of 53 in 2022 from 36 in 2021, surpassing 92% of the global peers and being significantly ahead of the industry average. more info >> |
|
Tuesday, September 6, 2022 |
|
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy |
more info >> |
|
Friday, August 26, 2022 |
|
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy |
more info >> |
|
Monday, April 26, 2021 |
|
Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation |
China Medical System Holdings Limited (0867.HK) ("CMS" or the "Company") has been active in the market this year. more info >> |
|
泰諾麥博宣佈完成4.5億元人民幣A輪融資 |
近日,珠海泰諾麥博生物技術有限公司(Trinomab Biotech Co., Ltd. 簡稱“泰諾麥博”或“Trinomab”)宣佈完成4.5億元人民幣的A輪融資,此次融資由高瓴創投領投,康哲藥業、藥明生物產業基金、無錫國聯等共同參與完成。 more info >> |
|
泰诺麦博宣布完成4.5亿元人民币A轮融资 |
近日,珠海泰诺麦博生物技术有限公司(Trinomab Biotech Co., Ltd. 简称“泰诺麦博”或“Trinomab”)宣布完成4.5亿元人民币的A轮融资,此次融资由高瓴创投领投,康哲药业、药明生物产业基金、无锡国联等共同参与完成。 more info >> |
|
Monday, April 5, 2021 |
|
China Medical System (0867.HK) Accelerating Development and Stepping to New Heights, Driven by Innovation |
As the earning season approaches, once again listed pharmaceutical companies are attracting the attention of the public. Recently, China Medical System Holdings Limited ("CMS" or the "Company") has released its annual results, with both revenue and profit higher than market expectations. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
特步宣布战略性出售K-Swiss及帕拉丁 并优化财务结构
May 9, 2024 20:28 HKT/SGT
|
|
|
特步宣佈戰略性出售K-Swiss及帕拉丁 並優化財務結構
May 9, 2024 20:25 HKT/SGT
|
|
|
Xtep Announces Strategic Divestiture of K-Swiss and Palladium and Enhanced Financial Structure
May 9, 2024 20:18 HKT/SGT
|
|
|
Paltalk, Inc. Reports Slight Increase in Revenue and 33% Reduction in Net Loss for First Quarter 2024
May 9, 2024 20:39 JST
|
|
|
ソニー独自のマイクロサージャリー支援ロボットを開発
May 9, 2024 18:00: JST
|
|
|
Honda、インドでの電動化の加速に向けた研究開発拠点をベンガルールに開設
May 9, 2024 13:50: JST
|
|
|
LEXUS、「LM」に6座仕様車を追加設定
May 9, 2024 13:45: JST
|
|
|
富士通、がんのタイプ分けなどのゲノム医療分野の課題を世界最高精度で解く、説明可能なAI技術を開発
May 9, 2024 13:30: JST
|
|
|
Honda Opens New R&D Facility in Bengaluru to Accelerate Electrification in India
May 9, 2024 14:13 JST
|
|
|
Malaysian Retail Sector Sees a 173% Growth in Hiring: foundit Insights Tracker
May 9, 2024 12:00 HKT/SGT
|
|
|
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
May 9, 2024 10:41 JST
|
|
|
Solar & Storage Live Philippines Leading Sustainability And Innovation In The Philippines Energy Sector
May 9, 2024 08:19 HKT/SGT
|
|
|
Saakuru and Blockpass Partner for Compliance in the Best Economic Opportunities Web3 Offers
May 9, 2024 08:00 HKT/SGT
|
|
|
Avance Clinical, 한국에서 새로운 임상 운영으로 APAC 지역으로 더 확장
May 9, 2024 08:00 HKT/SGT
|
|
|
SMC Announces LOI to Acquire Chaintrade LTD.
May 9, 2024 07:59 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|